Synapse Biomedical Inc. of Oberlin announced it has received the U.S. Food and Drug Administration’s Emergency Use Authorization for a new system to help wean patients off ventilators during the COVID-19 pandemic.
When Synapse Biomedical was founded, it became one of the first companies to receive funding from JumpStart, a northeast Ohio partner of Ohio Third Frontier. The organization also assigned Synapse Biomedical an entrepreneur-in-residence to help the company complete the different legal and financial processes required to start a business.
Synapse Biomedical recently partnered with Case Western Reserve University on a $3 million Innovation Platform Program grant from Ohio Third Frontier. The company will use this funding to begin manufacturing an advanced platform version of its devices in-house. By doing so, the company hopes to expand its technology to help those who have difficulties with hand grip, standing and bladder control.
Click here to read the full story.
Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell
Originally published April 13, 2020.